Female genital warts: global trends and treatments
SA Gall - Infectious diseases in obstetrics and gynecology, 2001 - Wiley Online Library
The increasing incidence of human papillomavirus (HPV) infection and HPV‐associated
conditions such as genital warts in women is a global concern. Genital warts are a clinical …
conditions such as genital warts in women is a global concern. Genital warts are a clinical …
Using imiquimod for genital warts in female patients
JT Cox, KU Petry, E Rylander, M Roy - Journal of Women's Health, 2004 - liebertpub.com
Genital warts (GW) are the manifestation of infection with specific types of human
papillomavirus (HPV), one of the most common sexually transmitted viral infections in the …
papillomavirus (HPV), one of the most common sexually transmitted viral infections in the …
Genital warts treatment: Beyond imiquimod
J Yuan, G Ni, T Wang, K Mounsey… - Human vaccines & …, 2018 - Taylor & Francis
Genital warts are one of the most common sexually transmitted diseases worldwide. The
disease is a result of infection with low-risk types of human papillomaviruses, mostly type 6 …
disease is a result of infection with low-risk types of human papillomaviruses, mostly type 6 …
Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day
KH Fife, A Ferenczy, JM Douglas Jr… - Sexually transmitted …, 2001 - journals.lww.com
Background Medical therapy for genital warts remains suboptimal. The topical interferon and
cytokine inducer, imiquimod, has been proved effective for the treatment of external genital …
cytokine inducer, imiquimod, has been proved effective for the treatment of external genital …
New approach to managing genital warts
CC Lopaschuk - Canadian Family Physician, 2013 - cfp.ca
Objective To summarize and determine the appropriate use for the new and old
management tools for genital warts. Sources of information The following databases were …
management tools for genital warts. Sources of information The following databases were …
An open-label phase II pilot study investigating the optimal duration of imiquimod 5% cream for the treatment of external genital warts in women
SM Garland, R Waddell, A Mindel… - … journal of STD & …, 2006 - journals.sagepub.com
Our objective was to determine the optimal duration of treatment with imiquimod for external
genital warts over 4, 8, 12 or 16 weeks. A total of 120 women with a history of genital warts …
genital warts over 4, 8, 12 or 16 weeks. A total of 120 women with a history of genital warts …
Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations
DN Sauder, RB Skinner, TL Fox… - Sexually transmitted …, 2003 - journals.lww.com
Topical Imiquimod 5% Cream as an Effective Treatment for Ext... : Sexually Transmitted Diseases
Topical Imiquimod 5% Cream as an Effective Treatment for External Genital and Perianal Warts …
Topical Imiquimod 5% Cream as an Effective Treatment for External Genital and Perianal Warts …
Therapeutic approaches to genital warts
KR Beutner, A Ferenczy - The American journal of medicine, 1997 - Elsevier
Although many treatments are available for genital warts caused by human papillomavirus
(HPV), none are uniformly successful in the treatment of this disease. Most current treatment …
(HPV), none are uniformly successful in the treatment of this disease. Most current treatment …
[引用][C] Increased frequency of dosing of imiquimod 5% cream in the treatment of external genital warts in women
KF Trofatter Jr, A Ferenczy, KH Fife… - … of Gynecology & …, 2002 - Wiley Online Library
Patients were treated until complete resolution of baseline warts was confirmed, or for up to
16 weeks, and then entered a 4-week observation period. Patients were monitored for …
16 weeks, and then entered a 4-week observation period. Patients were monitored for …
Management of genital warts
CM Kodner, S Nasraty - American family physician, 2004 - aafp.org
Genital warts caused by human papillomavirus infection are encountered commonly in
primary care. Evidence guiding treatment selection is limited, but treatment guidelines …
primary care. Evidence guiding treatment selection is limited, but treatment guidelines …